PHARMING GROUP NV (PHGN.DE) Stock Earnings & Estimates
Europe - Frankfurt Stock Exchange - FRA:PHGN - NL0010391025 - Common Stock
1.511 EUR
+0.02 (+1.21%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 205.622M 3.39% | 245.316M 19.30% | 297.2M 21.15% | 372.07M 25.19% | 388.69M 4.47% | 401.68M 3.34% | 403.89M 0.55% | 452.7M 12.08% | 526.01M 16.19% | 485.44M -7.71% | |
| EBITDA YoY % growth | 23.555M -45.99% | -5.825M -124.73% | 12.476M 314.18% | 24.849M 99.17% | 30.205M 21.55% | 43.003M 42.37% | 78.826M 83.30% | 134.3M 70.38% | 235.66M 75.47% | N/A | |
| EBIT YoY % growth | 10.367M -56.80% | -21.75M -309.80% | -3.594M 83.48% | 18.377M 611.32% | 28.634M 55.81% | 31.705M 10.73% | 46.009M 45.12% | 117.35M 155.06% | 218.33M 86.05% | 42.453M -80.56% | |
| Operating Margin | 5.04% | -8.87% | -1.21% | 4.94% | 7.37% | 7.89% | 11.39% | 25.92% | 41.51% | 8.75% | |
| EPS YoY % growth | N/A 101.60% | -0.02 -132.92% | -0.02 -12.50% | 0.02 234.87% | 0.04 61.90% | 0.04 -6.18% | 0.06 66.48% | 0.12 91.11% | 0.22 91.40% | N/A |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.01 71.60% | 0.03 240.45% | 0.02 243.33% | 0.01 3.00% | 0.01 20.05% |
| Revenue Q2Q % growth | 104.74M 13.02% | 95.79M 21.11% | 92.185M -1.09% | 89.61M -7.90% | 88.58M -15.43% |
| EBITDA Q2Q % growth | 11.433M -49.63% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 14.214M 112.15% | 16.274M 2,052.65% | 10.197M -21.25% | 7.21M -55.00% | 4.017M -71.74% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 0.01 600.00% | 0.00 | 0.01 | 1,070.87% |
| Q2 2025 Q2Q % growth | 0.01 400.00% | -0.03 | 0.03 | 123.30% |
| Q1 2025 Q2Q % growth | -0.02 -15.79% | -0.02 | -0.01 | -42.39% |
| Q4 2024 Q2Q % growth | 0.01 225.00% | 0.01 | 0.00 | -27.22% |
| Q3 2024 Q2Q % growth | 0.00 -140.00% | 0.00 | 0.00 | 22.33% |
| Q2 2024 Q2Q % growth | 0.00 | 0.01 | -0.01 | -124.27% |
| Q1 2024 Q2Q % growth | -0.02 -11.76% | 0.01 | -0.03 | -363.52% |
| Q4 2023 Q2Q % growth | 0.00 80.00% | 0.01 | -0.01 | -138.83% |
| Q3 2023 Q2Q % growth | 0.01 -61.54% | -0.03 | 0.03 | 118.67% |
| Q2 2023 Q2Q % growth | 0.00 -100.00% | -0.01 | 0.01 | 100.00% |
| Q1 2023 Q2Q % growth | -0.02 | -0.01 | -0.01 | -153.92% |
| Q4 2022 Q2Q % growth | -0.02 | 0.01 | -0.03 | -430.23% |
| Q3 2022 Q2Q % growth | 0.01 1,201.69% | 0.00 | 0.01 | % |
| Q2 2022 Q2Q % growth | 0.00 -66.78% | 0.01 | -0.01 | -61.66% |
| Q4 2021 Q2Q % growth | 0.00 -100.00% | 0.00 | 0.00 | % |
| Q3 2021 Q2Q % growth | 0.00 -110.09% | 0.00 | 0.00 | % |
| Q2 2021 Q2Q % growth | 0.01 -21.87% | 0.02 | -0.01 | -30.05% |
| Q1 2021 Q2Q % growth | 0.01 9.23% | 0.01 | 0.00 | -7.25% |
| Q4 2020 Q2Q % growth | 0.02 | 0.01 | 0.01 | 76.63% |
| Q3 2020 Q2Q % growth | 0.01 | 0.02 | -0.01 | -40.11% |
| Q2 2020 Q2Q % growth | 0.02 | 0.02 | 0.00 | 2.61% |
| Q1 2020 Q2Q % growth | 0.01 | 0.02 | -0.01 | -38.37% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 97.3M 30.00% | 96.233M | 1.067M | 1.11% |
| Q2 2025 Q2Q % growth | 93.2M 25.79% | 85.758M | 7.442M | 8.68% |
| Q1 2025 Q2Q % growth | 79.094M 42.29% | 69.767M | 9.327M | 13.37% |
| Q4 2024 Q2Q % growth | 92.672M 14.10% | 83.166M | 9.506M | 11.43% |
| Q3 2024 Q2Q % growth | 74.849M 12.28% | 79.238M | -4.389M | -5.54% |
| Q2 2024 Q2Q % growth | 74.093M 34.97% | 76.668M | -2.575M | -3.36% |
| Q1 2024 Q2Q % growth | 55.586M 30.66% | 70.478M | -14.892M | -21.13% |
| Q4 2023 Q2Q % growth | 81.217M 48.69% | 74.933M | 6.284M | 8.39% |
| Q3 2023 Q2Q % growth | 66.661M 22.90% | 63.18M | 3.481M | 5.51% |
| Q2 2023 Q2Q % growth | 54.897M 9.47% | 54.363M | 534K | 0.98% |
| Q1 2023 Q2Q % growth | 42.541M -8.74% | 49.595M | -7.054M | -14.22% |
| Q4 2022 Q2Q % growth | 54.621M -72.53% | 61.724M | -7.103M | -11.51% |
| Q3 2022 Q2Q % growth | 54.238M 2.60% | 55.62M | -1.382M | -2.48% |
| Q2 2022 Q2Q % growth | 50.146M 0.95% | 53.198M | -3.052M | -5.74% |
| Q1 2022 Q2Q % growth | 46.617M 18.92% | % | ||
| Q4 2021 Q2Q % growth | 198.871M -6.27% | 57.508M | 141.363M | 245.81% |
| Q3 2021 Q2Q % growth | 52.864M 14.62% | 55.686M | -2.822M | -5.07% |
| Q2 2021 Q2Q % growth | 49.673M 26.40% | 69.371M | -19.698M | -28.40% |
| Q1 2021 Q2Q % growth | 39.199M -20.48% | 63.237M | -24.038M | -38.01% |
| Q4 2020 Q2Q % growth | 212.174M | 62.49M | 149.684M | 239.53% |
| Q3 2020 Q2Q % growth | 46.121M | 56.991M | -10.87M | -19.07% |
| Q2 2020 Q2Q % growth | 39.299M | 59.743M | -20.444M | -34.22% |
| Q1 2020 Q2Q % growth | 49.294M | 54.624M | -5.33M | -9.76% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | N/A | -27.9% | N/A |
| Revenue | 0% | N/A | 0.31% | N/A |